Literature DB >> 15050302

IL-4 in vitro production is upregulated in Alzheimer's disease patients treated with acetylcholinesterase inhibitors.

Alessandra Lugaresi1, Angelo Di Iorio, Carla Iarlori, Marcella Reale, Giovanna De Luca, Eleonora Sparvieri, Alessia Michetti, Pio Conti, Domenico Gambi, Giuseppe Abate, Roberto Paganelli.   

Abstract

Cytokines appear to be involved in the pathogenesis of Alzheimer's Disease (AD). Their modulation by treatment has been investigated only in a few studies. The aim of our study was to evaluate the effect of acetylcholinesterase inhibitors (AChEI) on Interleukin-4 (IL-4) production in AD patients. IL-4 levels were measured by ELISA on peripheral blood mononuclear cell cultures in the presence or absence of Concanavalin A or Phytohaemagglutinin. Linear regression analysis shows that patients who have been treated, have higher levels of IL-4 independently from age, gender and comorbidity. The increased production of IL-4 in AChEI treated patients might represent an additional mechanism through which AChEI act on AD progression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15050302     DOI: 10.1016/j.exger.2003.08.012

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  11 in total

1.  IL-4 Induces Cholinergic Differentiation of Retinal Cells In Vitro.

Authors:  Marcelo Gomes Granja; Luis Eduardo Gomes Braga; Raul Carpi-Santos; Leandro de Araujo-Martins; Nilson Nunes-Tavares; Karin C Calaza; Aline Araujo Dos Santos; Elizabeth Giestal-de-Araujo
Journal:  Cell Mol Neurobiol       Date:  2015-02-15       Impact factor: 5.046

2.  Are inflammatory profiles the key to personalized Alzheimer's treatment?

Authors:  Holly M Brothers; Donna M Wilcock
Journal:  Neurodegener Dis Manag       Date:  2013

3.  Treatment in vitro of retinal cells with IL-4 increases the survival of retinal ganglion cells: the involvement of BDNF.

Authors:  Leandro de Araujo-Martins; Raphael Monteiro de Oliveira; Gabriela Velozo Gomes dos Santos; Renata Cláudia Celestino dos Santos; Aline Araujo dos Santos; Elizabeth Giestal de Araujo
Journal:  Neurochem Res       Date:  2012-10-16       Impact factor: 3.996

Review 4.  Peripheral chemo-cytokine profiles in Alzheimer's and Parkinson's diseases.

Authors:  M Reale; N H Greig; M A Kamal
Journal:  Mini Rev Med Chem       Date:  2009-09       Impact factor: 3.862

Review 5.  Neuroinflammation in Alzheimer's disease; A source of heterogeneity and target for personalized therapy.

Authors:  C H Latta; H M Brothers; D M Wilcock
Journal:  Neuroscience       Date:  2014-10-05       Impact factor: 3.590

Review 6.  Recent advances in pre-clinical diagnosis of Alzheimer's disease.

Authors:  John Zhou; Marc Benoit; Md Golam Sharoar
Journal:  Metab Brain Dis       Date:  2021-04-26       Impact factor: 3.655

7.  Relation between pro-inflammatory cytokines and acetylcholine levels in relapsing-remitting multiple sclerosis patients.

Authors:  Marcella Reale; Federica de Angelis; Marta di Nicola; Elisabetta Capello; Maria di Ioia; Giovanna de Luca; Alessandra Lugaresi; Ada Maria Tata
Journal:  Int J Mol Sci       Date:  2012-10-03       Impact factor: 5.923

Review 8.  Is there a causal link between inflammation and dementia?

Authors:  Ana-Maria Enciu; Bogdan O Popescu
Journal:  Biomed Res Int       Date:  2013-06-06       Impact factor: 3.411

9.  Construction of AAV-rat-IL4 and Evaluation of its Modulating Effect on Aβ (1-42)-Induced Proinflammatory Cytokines in Primary Microglia and the B92 Cell Line by Quantitative PCR Assay.

Authors:  Marzieh Jamalidoust; Mehrdad Ravanshad; Mandana Namayandeh; Maryam Zare; Sadaf Asaei; Mazyar Ziyaeyan
Journal:  Jundishapur J Microbiol       Date:  2016-03-05       Impact factor: 0.747

Review 10.  Peripheral inflammatory biomarkers in Alzheimer's disease: a brief review.

Authors:  Jong-Chan Park; Sun-Ho Han; Inhee Mook-Jung
Journal:  BMB Rep       Date:  2020-01       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.